Edwards Lifesciences Corp (NYSE:EW)

142.45
Delayed Data
As of Jul 02
 -1.15 / -0.80%
Today’s Change
84.05
Today|||52-Week Range
150.41
+11.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line236.7M293.2M391.7M811.1M
 
 
 
 
 
Depreciation58.0M57.3M68.7M68.6M
 
 
 
 
 
Total Other Cash Flow50.1M3.7M-9.3M23.4M
 
 
 
 
 
Funds From Operations344.2M362.3M451.2M832.0M
 
 
 
 
 
Funds From/For Other Operating Expenses29.7M-11.5M-21.5M-190.3M
 
 
 
 
 
Net Cash Flow - Operating Activities314.5M373.8M472.7M1.0B
 
 
 
 
 
 
InvestingIncrease In Investments-645.6M-595.2M-827.6M-2.1B
 
 
 
 
 
Decrease In Investments362.1M665.1M526.7M1.6B
 
 
 
 
 
Capital Expenditures-82.9M-120.7M-109.0M-82.9M
 
 
 
 
 
Fixed Asset Disposal3.9M3.0M2.3M3.1M
 
 
 
 
 
Net Assets From Acquisitions -42.6M-36.6M0.00-15.0M
 
 
 
 
Other Investing - Uses0.000.00-4.0M-10.8M
 
 
 
Other Investing - Sources--900.0K--0.00
 
 
Net Cash Flow Investing-412.8M-90.5M-412.7M-633.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings526.1M407.0M1.3B226.3M
 
 
 
 
 
Long Term Debt Reduction-421.7M-367.5M-895.4M-239.0M
 
 
 
 
 
Net Proceeds Stock Sale59.5M100.1M45.5M113.3M
 
 
 
 
 
Common Preferred Redeemed-303.4M-344.1M-496.9M-300.9M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing6.0M58.0M76.7M49.4M
 
 
 
 
 
Other Uses - Financing1.7M9.1M0.002.1M
 
 
 
 
Net Cash Flow - Financing-135.2M-155.6M34.9M-153.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.6M12.0M14.6M-2.9M
 
 
 
 
 
 
Net Change In Cash-233.5M127.7M94.9M236.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account